Intercept and slope analysis of risk factors in chronic renal allograft nephropathy

Graft

Volumn 5, Issue 2, 2002, Pages 108-113

  Sijpkens, Yvo ^a   Zwinderman, Aeilko ^a   Mallat, Marko ^a   Boom, Henk ^a   De Fijter, Hans ^a   Paul, Leen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; HLA ANTIGEN CLASS 1; IMMUNOSUPPRESSIVE AGENT;

AGE; ANTIGEN PRESENTATION; ARTICLE; CADAVER KIDNEY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PROTEINURIA; RECIPIENT; RISK FACTOR; SENSITIZATION; SURVIVAL TIME;

EID: 0036218299     PISSN: 15221628     EISSN: None     Source Type: Journal    
DOI: 10.1177/1522162802005002010     Document Type: Article

References (32)

1. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Transplanted Organs
2. Histopathologic findings associated with a chronic, progressive decline in renal allograft function
3. Sharing cross-reactive groups of MHC class I improves long-term graft survival
4. The variable nature of chronic declines in renal allograft function
5. Factors affecting renal allograft function in long-term recipients
6. Significance of the donor age effect on kidney transplants
7. Increased immunogenicity and cause of graft loss of old donor kidneys
8. Delayed graft function influences renal function, but not survival
9. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection
10. Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology
11. Early versus late acute renal allograft rejection: Impact on chronic rejection
12. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
13. Antibodies and chronic organ graft rejection
14. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries
15. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival
16. HLA compatibility and organ transplant survival. Collaborative Transplant Study
17. Cellular immunology markers posttransplantation predictive of long-term graft outcome
18. Chronic allograft nephropathy: An update
19. Patient non-compliance: A major cause of late graft failure in cyclosporine-treated renal transplants
20. Immune responsiveness and renal transplantation
21. Transplant risks
22. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
23. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
24. Glomerular capillary pressures in long-surviving rat renal allografts
25. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study
26. Progression of kidney disease in chronic renal transplant rejection
27. Renal allograft protection with losartan in Fisher to Lewis rats: Hemodynamics, macrophages, and cytokines
28. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function
29. The role of protein traffic in the progression of renal diseases
30. Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
31. Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease
32. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure